Biotech | January 10, 2022
Novavax and Serum file EUA for Covovax in South Africa
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
DiaMedica said it plans to launch the trial later in 2026
The clinical program has benefited from extensive European Union support, including the IMI2 TRIC-TB and UNITE4TB projects, as well as funding from the EDCTP2 bEto-TB project
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
The deliveries bring the innovative medicine to communities heavily impacted by HIV just five months after U.S. FDA approval
Adcock Ingram has been a cornerstone of healthcare in South Africa, known for its trusted medication brands such as Panado, Myprodol, Epi-Max, Citro-soda and Allergex
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
Subscribe To Our Newsletter & Stay Updated
